UCLB, the wholly owned subsidiary technology commercialisation company of UCL, has appointed Dr Anne Lane as its new Managing Director. As part of UCL Innovatio [...]
About Lucy TuffinThis author has not yet filled in any details.
So far Lucy Tuffin has created 58 blog entries.
London, UK, December 17th, 2018. LifeArc, a leading UK medical research charity, is delighted to launch a new Technology Transfer Fellowship programme in partn [...]
Medical software developed at UCL that overlays tumour information from MRI scans onto ultrasound images can help guide surgeons conducting biopsies and improve [...]
The government has published the second Life Sciences Sector Deal, which outlines public and private sector investments into the sector. Investments into three [...]
A single infusion of FLT180a resulted in sustained mean Factor IX activity of 45%, with no toxicity or adverse effects, and eliminated need for patient infusion [...]
UCLTF has invested in a series A round for immuno-oncology company IGEM Therapeutics. The £5million funding round also included investment from Alsa Holdings an [...]
AI spinout Hazy, featured in a recent Forbes list selecting the 15 Machine Learning Companies to Watch in Europe. Hazy made the top 10, for its platform that al [...]
UCL Spin-out Engitix Closes £5m Financing to Progress Liver Disease & Pancreatic Cancer Drug Discovery Platform & PipelineLucy Tuffin2018-11-27T10:25:05+01:00
Engitix Ltd, a company pioneering the development of both tissue-specific and disease-specific human extracellular matrix (ECM) for accelerating and improving t [...]
SmartTarget Ltd, a spinout of UCL (University College London) that has developed a CE-approved device for precision prostate biopsy and focal therapy, is please [...]
Simon Goldman and David Grimm, who are responsible for managing investments for the UCL Technology Fund, the fund co-managed by UCLB and Albion Capital, have to [...]